Integrated platform drives compliant interactions across virtual, in-person and hybrid global events
BARCELONA, Spain, March 28, 2023 /PRNewswire/ — Veeva Systems (NYSE: VEEV) today announced that more than 100 life sciences companies are using Veeva CRM Events Management to plan and execute in-person, virtual, and hybrid events. Worldwide. With over a million medical and business events to date, Events Management is helping teams lead more impactful HCP and KOL education and interactions. among equals through channels.
GSK, Jazz Pharmaceuticals and Kyowa Kirin International advance in the creation of personalized and adaptable events:
“Our global events strategy is focused on meeting healthcare professionals and scientific leaders wherever they are, which requires a flexible approach both virtually and in person,” said Dave Yates, GSK’s global director of products. “By gaining a complete view of how experts engage, Veeva CRM Events Management helps us adapt to learning preferences to deliver relevant omnichannel experiences that help improve patient outcomes.”
“With our company and portfolio growing rapidly in recent years, we needed to move to a single application and support team to plan and execute promotional programs,” said Stephanie Fitch, senior director of marketing and field operations at Jazz Pharmaceuticals. “Veeva CRM Events Management provides us with a compatible, easy-to-use system that allows our field teams to focus on supporting their clients rather than program logistics.”
“Event planning has spanned a variety of formats adapting to the new ways customers choose to interact,” said Peter Kimble, director of CRM at Kyowa Kirin International. “As we’ve adapted to flexible event styles, we’ve relied on Veeva CRM Events Management to ensure compliance and deliver a complete view from start to finish, creating more relevant and thoughtful experiences.”
Events Management is fully integrated with Veeva CRM Suite to provide a 360-degree view of customers and digital touchpoints. Companies can offer more coordinated and cohesive multi-channel engagements that align with field sales initiatives and break down the silos between sales, medicine, and marketing. The solution’s business rules engine also complies with various regulatory guidelines with rule sets that check event details in real time. Integrated with Veeva CRM Approved Email and additional digital login capabilities, teams can seamlessly track event communications and attendee reporting to ensure compliance.
“The sales, medical and marketing teams have pivoted quickly to adapt to different event formats and the changing needs of HCP and KOL,” said Andy Fuchs, Veeva’s vice president of business strategy. “Because events are a crucial part of holistic engagement that builds stronger relationships with HCPs, companies are embracing new ways to make events more meaningful with Veeva CRM Events Management.”
Additional InformationTo learn more about Veeva CRM Events Management, visit: veeva.com/eu/crm/events-management Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
About Veeva Systems Veeva (NYSE: VEEV) is the world leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, from the world’s largest pharmaceutical companies to emerging biotech companies. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.
Veeva’s Forward-Looking Statements This release contains forward-looking statements regarding Veeva’s products and services and the expected results or benefits from the use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we are under no obligation to update such statements. There are numerous risks that could adversely affect our results, including the risks and uncertainties disclosed in our Form 10-Q for the period ended October 31, 2022, which can be found here (see pages 39 and 40 for a summary of the risks that may affect our business), and in our subsequent filings with the SEC, which you can access at sec.gov.
Contact:
Jeremy WhittakerVeeva Systems 49-695-095-5486jeremy.whittaker@veeva.com
Logo – https://mma.prnewswire.com/media/1488285…
View original content: https://www.prnewswire.com/news-releases/mas-de-100-biofarmaceuticas-aumentan-el-compromiso-impactante-con-veeva-crm-events-management-301783186.html
